Drug intelligence / Profile preview

sarcopenia decoction

Development stage: Preclinical
Lead developer: Shuguang Hospital
Administration: Oral

Overview

Sarcopenia decoction is a traditional Chinese medicine (TCM) formulation currently under clinical investigation for the treatment of sarcopenia. The clinical trial is being conducted by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, with support from the National Key New Drug Creation Project and the Special Clinical Research Project of Shanghai Municipal Health Commission. As a decoction, it is typically administered orally and is composed of multiple herbal ingredients, though the specific components and their individual mechanisms of action are not detailed in the available information.

Beyond the preview

Go deeper on sarcopenia decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on sarcopenia decoction.

Explore the full profile